Among these nuclear receptors, the FXR signaling pathway is largely involved in lipid metabolism and glucose homeostasis, as well as in the pathogenesis and progression of NAFLD [36, 37]. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.